Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Aurobindo Pharm
Aurobindo Pharm
BSE: 524804NSE: AUROPHARMAISIN: INE406A01037

22nd-Nov-2012 11:36Source: BSE

Aurobindo Pharm - Aurobindo Pharma appoints Mr. Arvind Vasudeva as Chief Executive Officer (Formulations)

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated November 22, 2012, titled "Aurobindo Pharma appoints Mr. Arvind Vasudeva as Chief Executive Officer (Formulations)."

More Announcements on:

15th-Jun-2017 10:44Source: BSE

Aurobindo Pharm - Press Release

15th-Jun-2017 10:25Source: NSE

Aurobindo Pharma Limited

14th-Jun-2017 16:10Source: NSE

Aurobindo Pharma Limited

7th-Jun-2017 18:42Source: BSE

Aurobindo Pharm - Transcript Of Earnings Call

1st-Jun-2017 09:52Source: NSE

Aurobindo Pharma Limited

31st-May-2017 10:32Source: BSE

Aurobindo Pharm - Updates

1 2 3 4 5 Next >>
Sections
Follow us on
Available On